StonvexLoading…
StonvexStonvexStonvexCore line items from NWE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $1.10B | $760.40M | $432.80M | $1.55B |
Operating Income | $231.63M | $163.69M | $102.08M | $300.45M |
Net Income | $143.56M | $96.74M | $65.09M | $194.13M |
EPS (Diluted) | $2.34 | $1.58 | $1.06 | $3.22 |
Total Assets | $7.85B | $7.71B | $7.63B | $7.60B |
Total Liabilities | $5.04B | $4.91B | $4.82B | $4.82B |
Cash & Equivalents | $2.53M | $6.40M | $4.15M | $9.16M |
Free Cash Flow OCF − CapEx | $-56.61M | $-23.42M | $52.92M | $-77.66M |
Shares Outstanding | 61.31M | 61.30M | 61.28M | 61.25M |